Key result
Adding clopidogrel to acetylsalicylic acid in patients with TIA or ischaemic stroke resulted in a stroke rate of 4.9% vs 6.1% with placebo (HR 0.80; 95% CI 0.62-1.03).
Why the study?
Does clopidogrel added to acetylsalicylic acid reduce stroke in patients with transient ischaemic attack or ischaemic stroke?
Population
4,320 patients with transient ischaemic attack or ischaemic stroke
Comparison
Clopidogrel added to background therapy with… vs Placebo added to background therapy with…
Design
RCT, randomised, double-blind, placebo-controlled
Authors
Loading...
Does not support adding clopidogrel to aspirin after TIA or ischaemic stroke; leaves open benefit for confirmation in larger trials.
RCT (n=4,320)
double-blind
randomised
Does clopidogrel added to acetylsalicylic acid reduce stroke in patients with transient ischaemic attack or ischaemic stroke?
Hazard Ratio: 0.8 (95% CI 0.62–1.03)
Absolute Event Rate: 4.9% vs 6.1%
The addition of clopidogrel to aspirin in patients with TIA or ischemic stroke shows a non-significant trend towards reduced stroke without significantly increasing severe bleeding, generating a hypothesis for future dedicated trials.
Hankey et al. (2011) conducted an RCT in Transient ischaemic attack and ischaemic stroke (n=4,320). Clopidogrel vs. Placebo was evaluated on stroke (HR 0.80, 95% CI 0.62-1.03). Adding clopidogrel to acetylsalicylic acid in patients with TIA or ischaemic stroke resulted in a stroke rate of 4.9% vs 6.1% with placebo (HR 0.80; 95% CI 0.62-1.03).
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: